Abstract Submission Guidelines

ISHG 2024

January 21-24, 2024 | Ahmedabad

Members and non-members are encouraged to submit their latest research for programming at the ISHG 2024 Annual Meeting. Hundreds of abstracts will be accepted and programmed either as platform talks (oral presentations) or poster presentations.

SUBMISSIONS CLOSED

By submitting an abstract, you will benefit from a creative, idea-generating environment by getting feedback from global experts, sparking ideas through conversation, and forging collaborations across institutions and disciplines. Speaking slots are prioritized for abstracts presenting exciting, mature work. Findings should be novel and represent a significant advance in the field. Submitting an abstract can also make you eligible for the ISHG-Young Scientist Award and the ISHG Travel Grant!

Abstract Rules and Policies

  • An individual may be first (presenting) author of only one abstract.
  • The presenting author’s name should be the first name to appear in the author listing.
  • The first (presenting) author must present the gene symbol and/or name the identified marker at the meeting if you are reporting the mapping, linkage, or association of a locus to a phenotype. Authors who do not conform to this policy at the meeting will be subject to sanctions as determined by the Program Committee.
  • There is no limit to the number of times an individual may appear as co-author on abstracts.
  • Co-authors do not receive communication related to the abstract. First authors are responsible for coordinating communication with co-authors.
  • I have read, understand, and agree to the Abstract Submission Rules and Meeting Policies, including Code of Conduct.
  • I understand that in submitting an abstract, I am authorizing ISHG to contact me about its Annual Meeting, including the status of my abstract.
  • I will submit only one abstract as first author. I understand I can only speak and moderate for one accepted proposal. This includes if I have been accepted as an invited session speaker.
  • I understand that as first author, I must notify all authors of any and all correspondence relating to this abstract submission.
  • I confirm that each co-author has been informed of this abstract submission and has agreed to all information as it was submitted.
  • I verify that any reported human participants research was conducted with participants’ voluntary, informed consent, with approval by an appropriate research ethics committee, and consistent with the principles of research ethics, such as those described in the Declaration of Helsinki, and the Belmont Report.
  • I am submitting this abstract with the intent of attending and presenting my work in person at the Indian Society of Human Genetics Annual Meeting being held 21st to 24th January 2024, in Ahmedabad. I understand that if I do not register and attend in person, my abstract may be withdrawn and my opportunity to present in Ahmedabad forfeited. I understand that ISHG is not making any commitments to host virtual or hybrid content formats and reserves the right, at its sole discretion, to make adjustments to presentation format and style.
  • Presenting Author Disclosure: If my abstract is accepted as a platform or plenary (oral) presentation, I understand that I must include a conflict-of-interest slide as part of my presentation and that I must provide verbal and written disclosures to attendees.
  • Presenting Author Disclosure: If my abstract is accepted as a platform or plenary (oral) presentation, I agree to use generic names (i.e., non-branded names) in my presentation as much as possible. Specific products of ineligible companies will neither be promoted nor disparaged. The content of my presentation will not contain advertisements for a specific product, company, and/or service nor contain any logos of an ineligible company. In addition, I agree to disclose on the required disclosure slide any unlabeled/unapproved uses of drugs or products referenced in my presentation/materials.

A major goal of the ASHG Annual Meeting is to showcase leading edge research that is new to the field and appears in an international forum for the first time. If the findings in this abstract submission have been or will be published elsewhere prior to 30th September, 2023, authors should make clear what new information will be presented.

  • It is the authors’ responsibility to update the submission concerning any acceptances that occur before the submission deadline of September 30.
  • For abstracts that are previously published, authors are strongly encouraged to describe any advancement beyond published work that will be presented.
  • At time of assigning platform talks, the Program Committee will independently verify whether there is a publication available with an acceptance date before September 30. Failure to disclose prior publication will result in abstracts being deprioritized for oral presentation in plenary or platform sessions.

For purposes of this policy, “previously published” means:

  1. Accepted for peer-reviewed publication, or
  2. Accepted for oral presentation at other conferences

Material posted on a preprint server is NOT considered previously published.

Abstract Review

After the October 31 deadline, abstracts will be reviewed by the Scientific Committee (SC). The Committee programs abstracts as follows:

  • Abstracts are reviewed to ensure they have been submitted to the correct topic category. If not, the abstract is moved to a more appropriate topic, where it can be reviewed by appropriate experts.
  • Each abstract is reviewed by four SC reviewers.
  • This review step is blinded and strictly confidential. Each reviewer scores the abstracts independently, without knowledge of the name(s) and institution(s) of the submitter(s) or the scores given by the other reviewers.
  • In October, the Scientific Committee meets to assign abstracts to Platform and Poster Sessions based on the cumulative score as well as the impact of the science and the balance of topics for ISHG’s multi-disciplinary audience.
    • Approximately 8 abstracts are selected for oral ISHG-Young Scientist Award Session.
    • Approximately 120 accepted abstracts are assigned to posters, and the top-scoring poster abstracts are awarded the Reviewers’ Choice designation.
  • The Scientific Committee reserves the right to decline a presentation to any submitted abstracts that lack scientific content or merit or that merely announce the availability of a resource or service.
  • Abstract acceptance notifications will be sent to authors in November. Abstracts are programmed into the following session types:
    • ISHG Young Scientist Award
    • Poster Sessions
      • Reviewer’s Choice Recognition

Abstract Guidelines

  • Title should follow sentence case format: Human genetics is great: Analysis of the ISHG gene confirms enormous potential of the field.
  • Title should begin with a capital letter and should have a period at the end (unless you have other punctuation, such as a question mark). Do not use all caps. Abstracts with titles in ALL CAPS may not be reviewed. Maximum 255 characters (including spaces).
    • Only use additional capital letters as appropriate (e.g., Genome-wide linkage analysis using SNP genotyping set.; or Evidence of the XYZ mutation found in cancer patients with normal FISH tests.).
  • For gene/protein designations, please follow these guidelines set by The American Journal of Human Genetics: Human gene names and loci should be written in italicized capital letters and Arabic numerals. Protein product names should not be italicized.
  • Please use the italicized button where needed; do not enter special codes for bold or underline for your title. Text will automatically flow to the next line.
  • Special Characters: Please prepare your title using a program that includes the special characters necessary, then copy and paste your title into a word processing program with .txt file capability. Copy the text from Notepad/TextEdit and paste into the title box. Your special characters should be included.
  • When finished with your attestations and title entry, click “Save and Continue.” Your submission will be saved as an in-progress draft at this point. If you need to log out and return to the site later to finish, find the name of this abstract in the main dashboard and click on it to resume your progress.
  • The first (presenting) author cannot be the first author of another abstract being submitted.
  • Required information: first and last name, institution, institution city, institution country, mobile phone, email address, contact city, contact country, and additional information questions.
  • The first author’s name on a submitted abstract cannot be changed.
    • If you notice that your name is incorrect after payment and completion of the abstract submission, do not withdraw or delete a paid abstract submission to make edits or submit a new abstract. Refunds will not be issued for abstracts that are withdrawn, and payment will be required for any resubmissions. Contact ISHG’s Scientific Program Team (ishg2024@frige.co.in) for assistance.
    • If you notice that your name is incorrect prior to paying and completing the submission, then you must 1) withdraw your abstract submission by clicking “Delete This Submission” on the Review My Work step or by clicking the “Delete” icon on the Abstract Submission Site portal, 2) update your name in the ISHG portal, and then 3) submit a new abstract by 30th September, 2023.
    • If the first author has changed, then withdraw the abstract and ask the new first author to log in and submit a new abstract by 30th September, 2023. Note: Refunds will not be issued for abstracts that are withdrawn, and payment will be required for any resubmissions.
  • Enter the address and affiliation information in upper and lowercase as it should be published. Do not use special characters in the name or address fields. If applicable, include international dialing codes for phone numbers.
  • Affiliation and address changes you enter will not affect your membership affiliation and/or address.
  • ISHG does not permit co-first author designations.
  • You will have an opportunity to enter additional institutional affiliations after you have saved your initial first author data. Click “Add Institution” once you return to the Author(s) step to begin adding additional institutions. A maximum of five (5) affiliations per person are permitted.
  • Click “Save and Continue.” Your submission will be saved as an in-progress draft at this point. If you need to log out and return to the site later to finish, find the name of this abstract in the main dashboard and click on it to resume your progress.
  • Click “Add Author” on the Author(s) step to begin adding a co-author to your submission.
  • Search the co-author name by entering the last name, first name (exact match; use “*” for wildcard), or email address. Then click the search button.
  • Select the appropriate co-author (if found) by clicking the “Add” button next to their name in the search results.
    • Once you have added someone, you may be asked to fill in additional information. Once you have filled in or reviewed the co-author’s information, click “Save and Continue” to return to the Author(s) step and see the newly added co-author’s information added to the Author Block text.
  • If you are including someone whose name does not appear in the search results, you will have an option to add them after your search. (Click on “Enter your author here!” to begin entering an author who is not already known to ISHG.) You will be required to provide first and last name, institution, and email address to add a co-author. Once you have filled in and reviewed the co-author’s information, click “Save and Continue” to return to the Author(s) step and see the newly added co-author’s information added to the Author Block text.
  • If you need to edit a co-author’s affiliation, click the “Edit” link next to their name after adding them to your submission. Once you have finished editing the co-author’s information, click “Save and Continue” to return to the Author(s) step.
  • Enter the institutional affiliation information using upper and lowercase as it should be published. If multiple authors are from the same institution, enter each institution using similar naming convention to appear as a single affiliation in the program.
  • Do not enter special codes for bold, italic, or underline.
  • Add all authors in the order they should appear. (You will have an opportunity to re-order the co-authors after you add them. See Step 6 for detailed instructions.)
  • A maximum of thirty (30) authors can be listed plus any groups/consortia. Co-first and co-last authors are not permitted on ASHG abstracts.
  • If you wish to cite a group or consortium as a co-author, click the “Add a Group” link, then enter the group/consortium. Names of individual authors should not be entered here. This entry will appear in your abstract following the last individual co-author’s name. A group or consortium cannot be cited as the sole (i.e., first/presenting) author on an abstract. First (presenting) authors must be individuals who represent groups/consortia. When finished adding the group name, click “Save and Continue” to return to the Author(s) step.
  • When finished adding or editing co-authors review the Author Block text to ensure it is accurate, then click “Save and Continue.” Your submission will be saved as an in-progress draft at this point. If you need to log out and return to the site later to finish, find the name of this abstract in the main dashboard and click on it to resume your progress.
  • Once you add more than one co-author, you may rearrange the order of these authors if needed by clicking on the “Change the Order these Author(s) are listed” link.
  • Use the dropdown to select the appropriate number choice for each author.
  • You cannot change the order of the first (presenting) author.
  • When finished editing the order of co-authors, click “Save and Continue” to return to the Author(s) step.
  • You are allotted 2,300 characters, excluding spaces, for the body of your abstract. Title, author, and institutional data should not be included in the abstract body text. The submission will remain incomplete, and will not be reviewed, if the character limit is exceeded. Characters will be counted as you enter your abstract text. Make sure your abstract adheres to the style guide outlined below.
  • Click the “Enter Abstract Text” link and type or paste your abstract text into the text box.
    • Step 1: Prepare your abstract in a program such as Word or a text editor like Notepad/TextEdit. Do not copy and paste directly from a Word file as you may receive an error message due to embedded formatting. Save your file as a text (.txt) format.
      • Special Characters: To insert special characters or symbols, you must prepare your abstract in a program that includes special characters.
    • Step 2: Copy from your plain text file and paste into the Abstract text box. Your special characters should be retained.
    • Step 3: Click “Save and Continue” to return to the Abstract step and review the body text you entered.
  • Graphics and halftones cannot be submitted as part of your abstract.
  • For gene/protein designations, please follow these guidelines set by The American Journal of Human Genetics: Human gene names and loci should be written in italicized capital letters and Arabic numerals. Protein product names should not be italicized.
  • Note: Abstracts are published as submitted. Please check for accuracy before submitting.
  • After you enter your initial abstract text, if you need to make further changes, you may edit it by selecting “Edit Abstract Text.”
  • Once you are satisfied with the abstract body text you entered, click “Save and Continue.” Your submission will be saved as an in-progress draft at this point. If you need to log out and return to the site later to finish, find the name of this abstract in the main dashboard and click on it to resume your progress.

Students/ delegates can submit abstract for posters and YSA oral presentation based on the following areas of human genetics:

  • Clinical Genetics
  • Molecular and cytogenetic diagnostics
  • Rare disease therapeutics
  • Complex traits and polygenic disorders
  • Epigenetics
  • Evolutionary and population genetics
  • Genetic counselling
  • Genetic, genome and epigenome databases and resources
  • Molecular effects of genetic variation
  • Omics technologies
  • Pharmacogenetics
  • Prenatal, perinatal and developmental genetics
  • Statistical genetics and genetic epidemiology
  • Cancer

You will be asked to select from the dropdown menu the track that most closely describes the work in your abstract.

Once a track is selected, click “Save and Continue.” Your submission will be saved as an in-progress draft at this point. If you need to log out and return to the site later to finish, find the name of this abstract in the main dashboard and click on it to resume your progress.

  • You will be asked to enter up to five (5) keyword codes in order of importance. Keyword codes aid in the review process and placement of the abstract in a session, if applicable. To view and select codes during the submission process, click, “View the full list.”
  • Enter the keyword codes by using the dropdown boxes provided. A minimum of one (1) keyword is required.
  • Once you have finished selecting keywords, click “Save and Continue.” Your submission will be saved as an in-progress draft at this point. If you need to log out and return to the site later to finish, find the name of this abstract in the main dashboard and click on it to resume your progress.
SUBMISSIONS CLOSED
Register Now Submit Abstract